Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Guan-yong Ou"'
Publikováno v:
Heliyon, Vol 10, Iss 17, Pp e36986- (2024)
The tumor immune microenvironment (TIME) significantly influences cancer progression and treatment. This study sought to uncover novel TIME-related glioma biomarkers to advance antitumor immunotherapies by integrating data from sequencing of bulk RNA
Externí odkaz:
https://doaj.org/article/89440174a05748b3b4bc610999eb7f18
Publikováno v:
Folia Neuropathologica, Vol 59, Iss 2, Pp 189-197 (2021)
Externí odkaz:
https://doaj.org/article/c9630c8145f64b53aeda1aaaba0f4b26
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Gliomas, including brain lower grade glioma (LGG) and glioblastoma multiforme (GBM), are the most common primary brain tumors in the central nervous system. Neuregulin (NRG) family proteins belong to the epidermal growth factor (EGF) family of extrac
Externí odkaz:
https://doaj.org/article/e41b2331f2c9457189832391ca7d7bac
Publikováno v:
Frontiers in Aging Neuroscience, Vol 13 (2021)
Neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD) and amyotrophic lateral sclerosis (ALS), are typically characterized by progressive neuronal loss and neurological dysfunctions in the nervous system, affect
Externí odkaz:
https://doaj.org/article/16e8e41fab9d41a79d2a2a019114d9f8
Publikováno v:
Brain Sciences, Vol 9, Iss 7, p 168 (2019)
Alzheimer’s disease (AD) is a neurodegenerative disorder that occurs mainly in the elderly and presenile life stages. It is estimated that by the year 2050, 135 million people will be affected by AD worldwide, representing a huge burden to society.
Externí odkaz:
https://doaj.org/article/acb59994d973450e8f91c2ddab3d2826
Publikováno v:
Journal of Cancer. 13:2281-2292
LAG1 longevity assurance homolog 2 (LASS2), a highly conserved transmembrane protein, has been reported in several cancer types. However, the roles of LASS2 in glioma biology remain elusive. In the present study, we investigated the expression of LAA
Publikováno v:
Journal of Cellular and Molecular Medicine
Low‐grade glioma (LGG) is a heterogeneous tumour with the median survival rate less than 10 years. Therefore, it is urgent to develop efficient immunotherapy strategies of LGG. In this study, we analysed mutation profiles based on the data of 510 L
Publikováno v:
Folia Neuropathologica, Vol 59, Iss 2, Pp 189-197 (2021)
Introduction Glioma is the most common primary brain tumour in adults. Numerous studies have shown that neuregulins (NRGs) may be involved in the formation of glioma. Although NRG1 has been extensively studied in glioma, the functions of NRG2 in glio
Publikováno v:
Journal of Alzheimer's disease : JAD. 82(1)
Background: Alzheimer’s disease (AD) is a chronic neurodegenerative disease that seriously impairs both cognitive and memory functions mainly in the elderly, and its incidence increases with age. Recent studies demonstrated that long noncoding RNAs
Publikováno v:
Frontiers in Aging Neuroscience
Frontiers in Aging Neuroscience, Vol 13 (2021)
Frontiers in Aging Neuroscience, Vol 13 (2021)
Neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD) and amyotrophic lateral sclerosis (ALS), are typically characterized by progressive neuronal loss and neurological dysfunctions in the nervous system, affect